Literature DB >> 10786688

HMSH6 alterations in patients with microsatellite instability-low colorectal cancer.

Y R Parc1, K C Halling, L Wang, E R Christensen, J M Cunningham, A J French, L J Burgart, T L Price-Troska, P C Roche, S N Thibodeau.   

Abstract

Two microsatellite instability (MSI) phenotypes have been described in colorectal cancer (CRC): MSI-H (instability at >30% of the loci examined) and MSI-L (MSI at 1-30% of the loci examined). The MSI-H phenotype, observed in both hereditary nonpolyposis colon cancer-associated CRC and approximately 15% of sporadic CRC, generally results from mutational or epigenetic inactivation of the DNA mismatch repair (MMR) genes hMSH2 or hMLH1. The genetic basis for the MSI-L phenotype, however, is unknown. Several other proteins, including hMSH3 and hMSH6, also participate in DNA MMR. Inactivating mutations of MSH6 in yeast and human tumor cell lines are associated with an impaired ability to repair single-base mispairs and small insertion-deletion loops but not large insertion-deletion loops. This suggests that hMSH6 mutations are more likely to be associated with a MSI-L phenotype than a MSI-H phenotype in CRC. To explore this possibility, we screened tumors from 41 patients with MSI-L CRC for hMSH6 mutations with conformation-sensitive gel electrophoresis (CSGE) and for hMSH6 protein expression by immunohistochemistry. Alterations found with CSGE were confirmed by DNA sequencing of normal and tumor tissue. One somatic (Asp389Asn) and 15 germ-line changes were found. Of the 15 germ-line changes, 9 were found in an intron (none involving splice junctions), and 6 were found in an exon (Gly39Glu, Leu395Val, and 4 silent alterations). Immunohistochemical staining for hMSH6 performed on 34 of the 41 tumors revealed strong nuclear hMSH6 expression in all of the cases. Overall, our results suggest that hMSH6 mutations do not play a major role in the development of sporadic CRC with a MSI-L phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786688

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

Authors:  Jill A Maxwell; Stewart P Johnson; Roger E McLendon; David W Lister; Krystle S Horne; Ahmed Rasheed; Jennifer A Quinn; Francis Ali-Osman; Allan H Friedman; Paul L Modrich; Darell D Bigner; Henry S Friedman
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

2.  Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.

Authors:  Frank A Sinicrope; Rafaela L Rego; Kenji Okumura; Nathan R Foster; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

3.  Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.

Authors:  Frank A Sinicrope; Rafaela L Rego; Nathan R Foster; Stephen N Thibodeau; Steven R Alberts; Harold E Windschitl; Daniel J Sargent
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 4.  Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?

Authors:  G S Charames; A L Millar; T Pal; S Narod; B Bapat
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

5.  Association between MSH6 G39E polymorphism and cancer susceptibility: a meta-analysis of 7,046 cases and 34,554 controls.

Authors:  Zuming Li; Lihua Kong; Ling Yu; Jiao Huang; Ke Wang; Shi Chen; Miao Yu; Sheng Wei
Journal:  Tumour Biol       Date:  2014-03-13

6.  Obesity is an independent prognostic variable in colon cancer survivors.

Authors:  Frank A Sinicrope; Nathan R Foster; Daniel J Sargent; Michael J O'Connell; Cathryn Rankin
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

7.  hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.

Authors:  Enikô Kámory; Orsolya Kolacsek; Szabolcs Ottó; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

8.  Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.

Authors:  R L Rego; N R Foster; T C Smyrk; M Le; M J O'Connell; D J Sargent; H Windschitl; F A Sinicrope
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

9.  Mismatch repair protein expression in colorectal cancer.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; Michael J Kerin
Journal:  J Gastrointest Oncol       Date:  2013-12

10.  Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific.

Authors:  Qihui Jim Zhai; Daniel Gustavo Rosen; Karen Lu; Jinsong Liu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.